Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy
Yong Lu, Qiang Wang,
Qing Yi
Dr. Mary and Ron Neal Cancer Center
Houston Methodist Hospital
Houston Methodist
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Anticancer Tc9 cells: Long-lived tumor-killing T cells for adoptive therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer
100%
T Cells
100%
Tumor Killing
100%
Adoptive Therapy
100%
IL-9
100%
Long-lived
100%
Cell-based
50%
Cell Subsets
50%
Adoptive Transfer
50%
Effector Function
50%
Immune Cells
50%
Tumor Tissue
50%
Anti-tumor Response
50%
CD8+ T
50%
Medicine and Dentistry
Neoplasm
100%
T Cell
100%
Adoptive Transfer
50%
Cytotoxic T-Cell
50%
Immunocompetent Cell
50%
T Cell Subset
50%
Immunology and Microbiology
T Cell
100%
Immunocompetent Cell
50%
Cytotoxic T-Cell
50%
T Cell Subset
50%